Biotelemetry Inc (BEAT)
$71.96 0.00 (0.00%)
17:43 EST BEAT Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 2.36B
PE Ratio -194.49
Volume (Avg. Vol.)
Day's Range 71.96 - 71.96
52-Week Range 27.35 - 73.10
Dividend & Yield N/A (N/A)
BEAT Stock Predictions, Articles, and Biotelemetry Inc News
- From InvestorPlace
- From the Web
Here are some triple-a stocks to buy that are primed to start the new year going strong.
As potential impacts from the trade war with China loom, these stocks to buy are far more prepared to weather the storm.
We shortlist four solid stocks that have striking earnings growth and positive estimate revisions. Compare Brokers....
The tone of trade is a definitive "risk on" with equities rallying, Treasury bonds pulling back and overall market breadth strong. The action in small-cap stocks has been particularly impressive, with the Russell 2000 set to cap a five-day winning streak.
With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market.
NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: BioTelemetry, Inc. (NASDAQ:BEAT) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BEAT to Royal Philips for $72.00 per share. If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by